Dopamine, urges to smoke, and the relative salience of drug versus non-drug reward

Tom P Freeman, Ravi K Das, Sunjeev K Kamboj, H Valerie Curran

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

When addicted individuals are exposed to drug-related stimuli, dopamine release is thought to mediate incentive salience attribution, increasing attentional bias, craving and drug seeking. It is unclear whether dopamine acts specifically on drug cues versus other rewards, and if these effects correspond with craving and other forms of cognitive bias. Here, we administered the dopamine D2/D3 agonist pramipexole (0.5 mg) to 16 tobacco smokers in a double-blind placebo-controlled crossover design. Visual fixations on smoking and money images were recorded alongside smoking urges and fluency tasks. Pramipexole attenuated a marked bias in initial orienting towards smoking relative to money but did not alter a maintained attentional bias towards smoking. Pramipexole decreased urges to smoke retrospectively after the task but not on a state scale. Fewer smoking words were generated after pramipexole but phonological and semantic fluency were preserved. Although these treatment effects did not correlate with each other, changes in initial orienting towards smoking and money were inversely related to baseline scores. In conclusion, pramipexole can reduce the salience of an addictive drug compared with other rewards and elicit corresponding changes in smoking urges and cognitive bias. These reward-specific and baseline-dependent effects support an 'inverted-U' shaped profile of dopamine in addiction.

LanguageEnglish
Pages85-92
Number of pages8
JournalSocial Cognitive and Affective Neuroscience
Volume10
Issue number1
Early online date12 Mar 2014
DOIs
StatusPublished - 1 Jan 2015

Fingerprint

Reward
Smoke
Dopamine
Smoking
Pharmaceutical Preparations
Semantics
Cross-Over Studies
Tobacco
Cues
Motivation
Placebos
pramipexole

Keywords

  • Adolescent
  • Adult
  • Affect/drug effects
  • Attention/drug effects
  • Benzothiazoles/pharmacology
  • Craving/drug effects
  • Cross-Over Studies
  • Cues
  • Dopamine/physiology
  • Dopamine Agonists/pharmacology
  • Double-Blind Method
  • Female
  • Humans
  • Male
  • Motivation/drug effects
  • Photic Stimulation
  • Reward
  • Smoking/psychology
  • Tobacco Use Disorder/psychology
  • Young Adult

Cite this

Dopamine, urges to smoke, and the relative salience of drug versus non-drug reward. / Freeman, Tom P; Das, Ravi K; Kamboj, Sunjeev K; Curran, H Valerie.

In: Social Cognitive and Affective Neuroscience, Vol. 10, No. 1, 01.01.2015, p. 85-92.

Research output: Contribution to journalArticle

Freeman, Tom P ; Das, Ravi K ; Kamboj, Sunjeev K ; Curran, H Valerie. / Dopamine, urges to smoke, and the relative salience of drug versus non-drug reward. In: Social Cognitive and Affective Neuroscience. 2015 ; Vol. 10, No. 1. pp. 85-92.
@article{298fdb4f264041579595703d406b9a0c,
title = "Dopamine, urges to smoke, and the relative salience of drug versus non-drug reward",
abstract = "When addicted individuals are exposed to drug-related stimuli, dopamine release is thought to mediate incentive salience attribution, increasing attentional bias, craving and drug seeking. It is unclear whether dopamine acts specifically on drug cues versus other rewards, and if these effects correspond with craving and other forms of cognitive bias. Here, we administered the dopamine D2/D3 agonist pramipexole (0.5 mg) to 16 tobacco smokers in a double-blind placebo-controlled crossover design. Visual fixations on smoking and money images were recorded alongside smoking urges and fluency tasks. Pramipexole attenuated a marked bias in initial orienting towards smoking relative to money but did not alter a maintained attentional bias towards smoking. Pramipexole decreased urges to smoke retrospectively after the task but not on a state scale. Fewer smoking words were generated after pramipexole but phonological and semantic fluency were preserved. Although these treatment effects did not correlate with each other, changes in initial orienting towards smoking and money were inversely related to baseline scores. In conclusion, pramipexole can reduce the salience of an addictive drug compared with other rewards and elicit corresponding changes in smoking urges and cognitive bias. These reward-specific and baseline-dependent effects support an 'inverted-U' shaped profile of dopamine in addiction.",
keywords = "Adolescent, Adult, Affect/drug effects, Attention/drug effects, Benzothiazoles/pharmacology, Craving/drug effects, Cross-Over Studies, Cues, Dopamine/physiology, Dopamine Agonists/pharmacology, Double-Blind Method, Female, Humans, Male, Motivation/drug effects, Photic Stimulation, Reward, Smoking/psychology, Tobacco Use Disorder/psychology, Young Adult",
author = "Freeman, {Tom P} and Das, {Ravi K} and Kamboj, {Sunjeev K} and Curran, {H Valerie}",
note = "{\circledC} The Author (2014). Published by Oxford University Press. For Permissions, please email: journals.permissions@oup.com.",
year = "2015",
month = "1",
day = "1",
doi = "10.1093/scan/nsu026",
language = "English",
volume = "10",
pages = "85--92",
journal = "Social Cognitive and Affective Neuroscience",
issn = "1749-5016",
publisher = "Oxford Univerity Press",
number = "1",

}

TY - JOUR

T1 - Dopamine, urges to smoke, and the relative salience of drug versus non-drug reward

AU - Freeman, Tom P

AU - Das, Ravi K

AU - Kamboj, Sunjeev K

AU - Curran, H Valerie

N1 - © The Author (2014). Published by Oxford University Press. For Permissions, please email: journals.permissions@oup.com.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - When addicted individuals are exposed to drug-related stimuli, dopamine release is thought to mediate incentive salience attribution, increasing attentional bias, craving and drug seeking. It is unclear whether dopamine acts specifically on drug cues versus other rewards, and if these effects correspond with craving and other forms of cognitive bias. Here, we administered the dopamine D2/D3 agonist pramipexole (0.5 mg) to 16 tobacco smokers in a double-blind placebo-controlled crossover design. Visual fixations on smoking and money images were recorded alongside smoking urges and fluency tasks. Pramipexole attenuated a marked bias in initial orienting towards smoking relative to money but did not alter a maintained attentional bias towards smoking. Pramipexole decreased urges to smoke retrospectively after the task but not on a state scale. Fewer smoking words were generated after pramipexole but phonological and semantic fluency were preserved. Although these treatment effects did not correlate with each other, changes in initial orienting towards smoking and money were inversely related to baseline scores. In conclusion, pramipexole can reduce the salience of an addictive drug compared with other rewards and elicit corresponding changes in smoking urges and cognitive bias. These reward-specific and baseline-dependent effects support an 'inverted-U' shaped profile of dopamine in addiction.

AB - When addicted individuals are exposed to drug-related stimuli, dopamine release is thought to mediate incentive salience attribution, increasing attentional bias, craving and drug seeking. It is unclear whether dopamine acts specifically on drug cues versus other rewards, and if these effects correspond with craving and other forms of cognitive bias. Here, we administered the dopamine D2/D3 agonist pramipexole (0.5 mg) to 16 tobacco smokers in a double-blind placebo-controlled crossover design. Visual fixations on smoking and money images were recorded alongside smoking urges and fluency tasks. Pramipexole attenuated a marked bias in initial orienting towards smoking relative to money but did not alter a maintained attentional bias towards smoking. Pramipexole decreased urges to smoke retrospectively after the task but not on a state scale. Fewer smoking words were generated after pramipexole but phonological and semantic fluency were preserved. Although these treatment effects did not correlate with each other, changes in initial orienting towards smoking and money were inversely related to baseline scores. In conclusion, pramipexole can reduce the salience of an addictive drug compared with other rewards and elicit corresponding changes in smoking urges and cognitive bias. These reward-specific and baseline-dependent effects support an 'inverted-U' shaped profile of dopamine in addiction.

KW - Adolescent

KW - Adult

KW - Affect/drug effects

KW - Attention/drug effects

KW - Benzothiazoles/pharmacology

KW - Craving/drug effects

KW - Cross-Over Studies

KW - Cues

KW - Dopamine/physiology

KW - Dopamine Agonists/pharmacology

KW - Double-Blind Method

KW - Female

KW - Humans

KW - Male

KW - Motivation/drug effects

KW - Photic Stimulation

KW - Reward

KW - Smoking/psychology

KW - Tobacco Use Disorder/psychology

KW - Young Adult

U2 - 10.1093/scan/nsu026

DO - 10.1093/scan/nsu026

M3 - Article

VL - 10

SP - 85

EP - 92

JO - Social Cognitive and Affective Neuroscience

T2 - Social Cognitive and Affective Neuroscience

JF - Social Cognitive and Affective Neuroscience

SN - 1749-5016

IS - 1

ER -